DC
INSIDER · URGN · UroGen Pharma Ltd. · CHIEF FINANCIAL OFFICER
Degnan Chris
Every open-market transaction filed under this name, Oct 8 to Oct 8.
Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$81K
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 8 | URGN | UroGen Pharma Ltd. | Chief Financial Officer | Sell | 2,202 | $36.69 | $81K | −0.2% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.